Outlook Therapeutics Inc (OTLK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 09-2015 | 12-2014 | 09-2014 | 12-2013 | 09-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 9,071 | 0 | 2,349 | 2,349 | 2,349 |
| Receivables | 4,300 | 4,300 | N/A | 0 | N/A |
| Other current assets | 0 | 0 | 0 | 797 | 797 |
| TOTAL | $15,164 | $4,300 | $3,147 | $3,147 | $3,147 |
| Non-Current Assets | |||||
| PPE Net | 17,760 | 0 | 8,010 | 8,010 | 8,010 |
| Other Non-Current Assets | 2,085 | 0 | 448 | 0 | 0 |
| TOTAL | $19,844 | $0 | $8,457 | $8,010 | $8,010 |
| Total Assets | $35,009 | $4,300 | $11,604 | $11,604 | $11,604 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 743 | 0 | 726 | 0 | N/A |
| Accounts payable and accrued liabilities | 11,563 | 0 | 3,101 | 0 | 0 |
| Accrued Expenses | 5,925 | 0 | 2,560 | 0 | N/A |
| TOTAL | $37,042 | $0 | $20,210 | $20,210 | $20,210 |
| Non-Current Liabilities | |||||
| Long Term Debt | 4,923 | 0 | 3,653 | 3,653 | 3,653 |
| Deferred Revenues | 1,980 | 0 | 1,501 | 0 | N/A |
| Other Non-Current Liabilities | 31,419 | 0 | 17,168 | 3,101 | 3,101 |
| TOTAL | $42,650 | $0 | $27,167 | $6,754 | $6,754 |
| Total Liabilities | $79,692 | $0 | $47,377 | $47,377 | $47,377 |
| Shareholders' Equity | |||||
| Common Shares | 39,845 | 0 | N/A | 0 | N/A |
| Retained earnings | -94,064 | 0 | -45,151 | -45,151 | -45,151 |
| Other shareholders' equity | 9,536 | 10,191 | 9,378 | 9,378 | 9,378 |
| TOTAL | $-44,683 | $10,191 | $-35,773 | $-35,773 | $-35,773 |
| Total Liabilities And Equity | $35,009 | $10,191 | $11,604 | $11,604 | $11,604 |